We would love to hear your thoughts about our site and services, please take our survey here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Acerflyer, The point I was making in my original response to your post of 3 Mar 2024 11:42 (before someone contrived to have it removed) was that there are a lot of significantly lower priced products for sale in pharmacies which are offered to provide an enhance pleasurable response which may be attractive for single man for solo s e x use and other mutual applications.
"hello...are you liam booth....."
No, Sparky, I am not. I am just Nic, no-one else. You didn't say if you'd tried tadalfil?
Anyone questioning Nicnack's intentions might like to revisit a post I made a few months ago:
LiarBOoth raising his ugly head again?16 Oct 2023 20:05
I see that old ID, NicName, has been dusted off again. Just like most bashers, he's started off with an innocuous question. He just asked Ah! Ananda: 'As you seem comfortable "talking about an ED product and (your) experiences using the product. Ahananda, would you mind saying if you are using it as someone suffering from erectile disfunction so we can appreciate the complete picture? (An rough indication of age and circumstance may also help with understanding.)'
Thank you for your feedback.' All very innocent looking until you scroll back to late 2021 when NicName was all over the board with his negative stock bashing. Here's a very mild one:
'NicName
Posts: 313Price: 35.80
RE: Eroxon - Coming soon11 Nov 2021 03:07
"my love for Eroxon will get even firmer with spectacular sales"
Unlike the majority of ED sufferers members to which it is applied, I fear.'
Looks like NicNack has already made his mind up!
Great thought - if anyone was on a one night stand going at it four times is asking a lot over the course of the night whereas if the lady was nice enough you can stretch to two tubes I suspect .
Not that I get up to any of this sort of stuff - I am of the age that is now called mid life.
Yes, the last RNS gave us a good indication of sales but future growth is what we need to hear about. April is only a month away so not long to wait before results and an update on where are currently.
They already said roughly how much they've made for the year end results.
I want to hear progress on the US, plus have they found someone in the Asian to release the product.
But I would like to hear some forward guidance on revenues, divis, something a bit more than they've done in the past....imo
Well at the moment. All we know is Erexon was the product of the year.
Roll on results when we can be put out of our misery and finally see some figures and most importantly what FUM are making.
Acerflyer we can can only ever see the online sales and using the Total of Boots sildefanil, Viagra , Cialiis and Eroxon it seems on average Eroxons share fluctuates between 15% and 25% depending. (sometimes much higher)
Obviously have no way of judging in store sales
Boots is the most expensive it seems
Said before it would be interesting if there was a box of 2 Tubes Eroxon for £10 to £12 as the Viagra £11.99 box of two sells well but larger more expensive ones dont
OK, on a separate Boots point, they have outlets in various overseas locations like Ireland and Norway (both now have Eroxon) and interestingly far flung places like Thailand - so this may be a route to getting into the Far East possibly?
@ acerflyer.
This has been discussed, disputed and speculated about several times here since Eroxon first went live on the Boots website.
I think the general consensus was, that the "24hr period" is a rolling 24 hr period, so figures will fluctuate accordingly.
But please do you're own research, post any pertinent findings here and give us all something to discuss.
Web says 33 bought in last 24 hours online or say 1,000 per month. Has anyone looked at this before and what numbers showed up.
Https://www.youtube.com/watch?v=CeHfrVccuW8&t=218s
Imagine being told to go to your doctor along the lines that I'm not getting enough morning woods any more .
Brave new world here for some of us - I can't say I have ever discussed this with a single soul.
Perhaps men need to get much more open about their mechanics down below.
Just picked up on the fact that renalytix has announced today that it is appointing stifel as advisor to deal with the formal sales process which it has launched today after the approach from a possible third party acquirer. fum ppointed stifel as its joint broker in middle of febuary, a move which i personally found extremely interesting. im certainly not suggesting that fum are about to launch a formal sale prices. far from it, as i am sure they will want the increasing sales rollout to have plenty of time to bear fruit, but i do think it is an indication of what the board sees as the future direction of travel. just felt it was interesting to make the reference, but obviously nothing more than speculation on my part at this point.
Nickname, why such avatar, are you looking for a nickname? How about Eroxon since you seem to be in ´love’ with the company for no reason hence your multiple avatars. Or Mr. Erection Dysfunction. Or better still Mr. Brain Dysfunction?
I think liquidity must be getting pretty tight as peeps are accumulating and will hold for the story to unfold.
This will suddenly start to move up the minute our big investors have completed their fill.
Statins are sourced from a simple fungi, are 3% effective and have serious side effects. Yet they generate over £20bn profit per year are the most profitable pharmaceutical product of ALL TIME !!!!!
...So Nickname (Liam?)
FUM tested
Europe CE accredited
Approved by FDA (Via extended study)
Approved by NICE for NHS
Due diligence by Atlantis Grp
Due diligence by Coopers
Due diligence by Haleon
Won Boots best product award
All these people got it wrong, it was a placebo effect after all, the daft people could not see it! .....And you did!
What a clever person you are.
Good find - 5 outlets already linked in and progress!
Nickname......hello...are you liam booth.....
"Nic…. Yes I do…"
Tried tadalafil?
Any PR savvy company would milk any SP affecting news, ie addition of a new country outlet. We hear it through the BB!
Am I missing something or is the company 'missing a trick'?
I've just checked FUM's website and they have added Norway to their list and it's avaible there. Still not avilable in Portugal and Italy...but the list is growing....
FUM tested
Europe CE accredited
Approved by FDA (Via extended study)
Approved by NICE for NHS
Due diligence by Atlantis Grp
Due diligence by Coopers
Due diligence by Haleon
Won Boots best product award
Vs
'Suspect' Boots feedback. (Do the math!)
Even if a small percentage of the established ED success rate is converted to sale + NHS users (UK) + the recreational users (which I feel will turnout to be the largest user group, in future), this will be BIG.
Someone mentioned L/O (Largest share holder 28.5%) exit strategy. IMO Don't hold your breath. This is a growth fund now.
I have no doubts that this is going to be a very popular product, whether one suffers from diagnosed ED, or not.
Apart from the ED market, There are numerous occasions whereby perfectly young & healthy men have erection issues, stress, overtired, ‘stage fright’ with a new partner, too much alcohol etc etc.
Having some gel handy, aswell as a condom or 2, will become the norm.
In regards to the reviews, The NHS has approved the product for prescription, so it has already undergone strict approval processes proving its effectiveness.
My interest at this stage is how much FUM is going to be worth within 6, 12, 18 months time?
If annual sales accelerate and Eroxon takes a minimum of 20% of the Global market (£4.7Bn) then consider our MCap then.
Personally, being able to buy OTC & use a product like Eroxon, that works within 10 minutes, without side effects, will Trump products that take an hour, such as Viagra, with a number of well documented side effects, plus an interview before one can purchase it.
So, I consider our market will gain increasing traction and eventual sales will be phenomenal.
Has anyone here actually tried the gel where they can say that the gel changed and improved the feelings down below much for the better. This aspect hardly gets discussed but it opens a new line of business for those men who simply want a more enjoyable experience even if they do not have ED. My sense is that very much can if you have the basic sensitivity in place. So you could in theory sell this to a single man for solo s e x